.Attribute Medicine, Published online: 03 September 2024 doi:10.1038/ s41591-024-03223-zThis Viewpoint calls for incorporation of individuals with MASLD and measurement of liver end results in cardio-- renal-- metabolic trials, when information propose mechanistically possible perks and medical safety-- and describes points to consider for test layout and also governing approval.